These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 11564532)
41. Neuritic pathology and dementia in Alzheimer's disease. McKee AC; Kosik KS; Kowall NW Ann Neurol; 1991 Aug; 30(2):156-65. PubMed ID: 1910274 [TBL] [Abstract][Full Text] [Related]
42. Nonisotopic in situ hybridization of amyloid beta protein precursor in Alzheimer's disease: expression in neurofibrillary tangle bearing neurons and in the microenvironment surrounding senile plaques. Hyman BT; Wenniger JJ; Tanzi RE Brain Res Mol Brain Res; 1993 May; 18(3):253-8. PubMed ID: 7684484 [TBL] [Abstract][Full Text] [Related]
43. No difference in the prevalence of Alzheimer-type neurodegenerative changes in the brains of suicides when compared with controls: an explorative neuropathologic study. Matschke J; Sehner S; Gallinat J; Siegers J; Murroni M; Püschel K; Glatzel M Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):509-517. PubMed ID: 29383449 [TBL] [Abstract][Full Text] [Related]
44. Is there a spatial association between senile plaques and neurofibrillary tangles in Alzheimer's disease? Armstrong RA Folia Neuropathol; 2005; 43(3):133-8. PubMed ID: 16245206 [TBL] [Abstract][Full Text] [Related]
45. Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer's brain. Gomez-Ramos P; Mufson EJ; Moran MA Brain Res; 1992 Jan; 569(2):229-37. PubMed ID: 1540829 [TBL] [Abstract][Full Text] [Related]
46. Stereological Quantification of Plaques and Tangles in Neocortex from Alzheimer's Disease Patients. Madsen JB; Folke J; Pakkenberg B J Alzheimers Dis; 2018; 64(3):723-734. PubMed ID: 29914026 [TBL] [Abstract][Full Text] [Related]
47. P38 MAP kinase is activated at early stages in Alzheimer's disease brain. Sun A; Liu M; Nguyen XV; Bing G Exp Neurol; 2003 Oct; 183(2):394-405. PubMed ID: 14552880 [TBL] [Abstract][Full Text] [Related]
48. Immunolocalization and redistribution of the FAC1 protein in Alzheimer's disease. Schoonover S; Davies P; Bowser R J Neuropathol Exp Neurol; 1996 Apr; 55(4):444-55. PubMed ID: 8786404 [TBL] [Abstract][Full Text] [Related]
49. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Schmitz C; Rutten BP; Pielen A; Schäfer S; Wirths O; Tremp G; Czech C; Blanchard V; Multhaup G; Rezaie P; Korr H; Steinbusch HW; Pradier L; Bayer TA Am J Pathol; 2004 Apr; 164(4):1495-502. PubMed ID: 15039236 [TBL] [Abstract][Full Text] [Related]
50. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex. Yilmazer-Hanke DM Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108 [TBL] [Abstract][Full Text] [Related]
51. Pathological substrates of cognitive decline in Alzheimer's disease. Giannakopoulos P; Gold G; von Gunten A; Hof PR; Bouras C Front Neurol Neurosci; 2009; 24():20-29. PubMed ID: 19182459 [TBL] [Abstract][Full Text] [Related]
52. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology. Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017 [TBL] [Abstract][Full Text] [Related]
53. [Neuropathological study on progression of the limbic degeneration in senile dementia of Alzheimer type]. Kasahara M; Mizutani T No To Shinkei; 1997 Jan; 49(1):51-8. PubMed ID: 9027902 [TBL] [Abstract][Full Text] [Related]
54. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946 [TBL] [Abstract][Full Text] [Related]
55. Differential modification of muscarinic cholinergic receptors in the hippocampus of patients with Alzheimer's disease: an autoradiographic study. Probst A; Cortés R; Ulrich J; Palacios JM Brain Res; 1988 May; 450(1-2):190-201. PubMed ID: 3401711 [TBL] [Abstract][Full Text] [Related]
56. Pyramidal neuron loss is matched by ghost tangle increase in Guam parkinsonism-dementia hippocampus. Schwab C; Steele JC; McGeer PL Acta Neuropathol; 1998 Oct; 96(4):409-16. PubMed ID: 9797006 [TBL] [Abstract][Full Text] [Related]
57. Hippocampal neurons in pre-clinical Alzheimer's disease. West MJ; Kawas CH; Stewart WF; Rudow GL; Troncoso JC Neurobiol Aging; 2004 Oct; 25(9):1205-12. PubMed ID: 15312966 [TBL] [Abstract][Full Text] [Related]
58. Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus. DiPatre PL; Gelman BB J Neuropathol Exp Neurol; 1997 Feb; 56(2):143-9. PubMed ID: 9034367 [TBL] [Abstract][Full Text] [Related]
59. Are routine methods good enough to stain senile plaques and neurofibrillary tangles in different brain regions of demented patients? Mavrogiorgou P; Gertz HJ; Ferszt R; Wolf R; Bär KJ; Juckel G Psychiatr Danub; 2011 Dec; 23(4):334-9. PubMed ID: 22075733 [TBL] [Abstract][Full Text] [Related]
60. Entorhinal cortex of aged subjects with Down's syndrome shows severe neuronal loss caused by neurofibrillary pathology. Sadowski M; Wisniewski HM; Tarnawski M; Kozlowski PB; Lach B; Wegiel J Acta Neuropathol; 1999 Feb; 97(2):156-64. PubMed ID: 9928826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]